Lowering the body temperature of preterm infants (born at 33 to 35 weeks of pregnancy) with hypoxic ischemic encephalopathy (HIE)-a type of brain damage caused by oxygen loss-offers no benefits over standard care, according to a study funded by the National Institutes of Health (NIH).
Horizon adds ‘severe hearing impairment’ warning to blockbuster’s label
The FDA recently added a new warning and precaution to the label of Horizon’s blockbuster monoclonal antibody Tepezza (teprotumumab-trbw), which is used as a treatment
July 21, 2023